LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Summary

RATIONALE: The LMB-9 immunotoxin may be able to locate tumor cells and kill them without harming normal cells. This may be an effective treatment for advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of LMB-9 immunotoxin in treating patients who have advanced solid tumors that have not responded to standard therapy.

Timeline

Start

1998-05

Primary completion

—

Completion

—

Drugs

Indications